[Taiwan Semiconductor Manufacturing Company Limited Page 1 PART I 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THE COMPANY 12 ITEM 4A. UNRESOLVED STAFF COMMENTS 21] [ARTICLES OF INC]
[2 SCHEDULE 13D G21515104 CUSIP No. 1. Names of Reporting Persons. Parfield International Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions). (a) ☒ (b) ◻ 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5. ☐ 6. Citizenship or Place of Organization British Virgin Islan]
[001-31914 中 國 人 壽 保 險 股 份 有 限 公 司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 2628) Announcement on the Resolutions of the Twenty-Fourth Meeting of the Sixth Session of the Board of Directors ]
[2 SCHEDULE 13D G21515104 CUSIP No. 1. Names of Reporting Persons. Parfield International Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions). (a) ☒ (b) ◻ 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5. ☐ 6. Citizenship or Place of Organization British Virgin Islan]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Company’s announcement dated 27 August 2004. The accumulated premium inco]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 DATE OF BOARD MEETING Aluminum Corporation of China Limited Date April 14, 2020 By About the Company Our contact information of this release is: * Business address: No]
[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]
[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]
[Changyou.com Announces Filing of Definitive Plan of Merger for Going-Private Transaction fully-vested Because Changyou Merger Co. owns over 90% of the voting power represented by all issued and outstanding shares of Changyou, the Changyou Merger will be in the form of a short-form merger of Changyou]
